Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Takeda reveals new GnRH antagonists in recently issued patent

Jan. 24, 2000

Immunomedics' bispecific fusion proteins covered by U.S. patent

Jan. 24, 2000

NCI to initiate phase III trial of Neovastat in the U.S. and Canada

Jan. 24, 2000

German colorectal cancer patients have new treatment option: Sanofi-Synthelabo's Eloxatin

Jan. 21, 2000

Human Genome Sciences initiates phase II clinical trial of repifermin for mucositis

Jan. 21, 2000

Pharmacia & Upjohn and Geron extend telomerase collaboration

Jan. 21, 2000

Myriad Genetics patent covers p19 therapeutic and diagnostic development

Jan. 20, 2000

Joint venture formed by Ribozyme and Elan to develop anticancer ribozyme product

Jan. 20, 2000

Clinical trial commences with Cell Therapeutics' novel paclitaxel

Jan. 20, 2000

Magainin presents new anticancer magainin peptide at H&Q

Jan. 20, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...